Guangzhou LBP Medicine Science & Technology (688393) Stock Overview
Guangzhou LBP Medicine Science & Technology Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 1/6 |
688393 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Guangzhou LBP Medicine Science & Technology Co., Ltd. Competitors
Shanghai General Healthy Information and Technology
Jiangsu Canopus Wisdom Medical TechnologyLtd
Allgens Medical Technology
Sichuan Gangtong Medical Equipment Group
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥29.10 |
| 52 Week High | CN¥46.59 |
| 52 Week Low | CN¥17.46 |
| Beta | 0.49 |
| 1 Month Change | 18.44% |
| 3 Month Change | 13.05% |
| 1 Year Change | 65.81% |
| 3 Year Change | 18.10% |
| 5 Year Change | -21.24% |
| Change since IPO | -51.88% |
Recent News & Updates
Recent updates
Returns On Capital Signal Tricky Times Ahead For Guangzhou LBP Medicine Science & Technology (SHSE:688393)
Mar 25
Guangzhou LBP Medicine Science & Technology Co., Ltd.'s (SHSE:688393) Business Is Trailing The Market But Its Shares Aren't
Feb 07Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Problems Go Beyond Poor Profit
Nov 06Guangzhou LBP Medicine Science & Technology Co., Ltd.'s (SHSE:688393) Shares May Have Run Too Fast Too Soon
Sep 30Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Weak Earnings May Only Reveal A Part Of The Whole Picture
Apr 29Some Confidence Is Lacking In Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHSE:688393) As Shares Slide 25%
Apr 23Guangzhou LBP Medicine Science & Technology Co., Ltd.'s (SHSE:688393) 31% Price Boost Is Out Of Tune With Earnings
Mar 09Shareholder Returns
| 688393 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | -16.4% | -3.6% | -0.02% |
| 1Y | 65.8% | 8.7% | 33.5% |
Return vs Industry: 688393 exceeded the CN Medical Equipment industry which returned 8.7% over the past year.
Return vs Market: 688393 exceeded the CN Market which returned 33.5% over the past year.
Price Volatility
| 688393 volatility | |
|---|---|
| 688393 Average Weekly Movement | 8.7% |
| Medical Equipment Industry Average Movement | 4.5% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in CN Market | 9.4% |
| 10% least volatile stocks in CN Market | 3.0% |
Stable Share Price: 688393's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 688393's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 779 | Xiangting Cai | www.gzlbp.com |
Guangzhou LBP Medicine Science & Technology Co., Ltd. engages in the research, development, and production of pathological diagnosis products in China and internationally. The company offers pathological diagnostic reagents and ancillary equipment that consists of liquid-based cytology products, including liquid-based cytology production machines and automatic sample transfer machines; polymerase chain reaction products, such as human papillomavirus gene test kits, sample preservation solutions, and automatic nucleic acid molecular hybridization instruments; fluorescence in situ hybridization products comprising auto-fish instruments, and AML1/ETO, EGFR, BCR/ABL fusion, PML/RARA, and TOP2A gene testing kits; and digital pathology products pathological medical image analysis processing systems, real-time microscopic visual field sharing systems, and bingli scanner.
Guangzhou LBP Medicine Science & Technology Co., Ltd. Fundamentals Summary
| 688393 fundamental statistics | |
|---|---|
| Market cap | CN¥2.67b |
| Earnings (TTM) | -CN¥19.11m |
| Revenue (TTM) | CN¥371.03m |
Is 688393 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688393 income statement (TTM) | |
|---|---|
| Revenue | CN¥371.03m |
| Cost of Revenue | CN¥137.98m |
| Gross Profit | CN¥233.05m |
| Other Expenses | CN¥252.16m |
| Earnings | -CN¥19.11m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
Apr 29, 2026
| Earnings per share (EPS) | -0.20 |
| Gross Margin | 62.81% |
| Net Profit Margin | -5.15% |
| Debt/Equity Ratio | 0.9% |
How did 688393 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/21 17:08 |
| End of Day Share Price | 2026/01/21 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Guangzhou LBP Medicine Science & Technology Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.